PHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2002
Amended Announcements
Please refer to the earlier announcement reference number: CR-030225-36299
| PHARMANIAGA BERHAD |
|
Quarterly report for the financial period ended | 31/12/2002 |
| Quarter | 4 |
| Financial Year End | 31/12/2002 |
| The figures | have been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2002 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2002 | 31/12/2001 | 31/12/2002 | 31/12/2001 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 129,787 | 139,516 | 585,237 | 543,496 |
| 2 | Profit/(loss) before tax | 11,287 | 14,914 | 61,170 | 51,604 |
| 3 | Profit/(loss) after tax and minority interest | 6,779 | 8,151 | 37,341 | 30,804 |
| 4 | Net profit/(loss) for the period | 6,779 | 8,151 | 37,341 | 30,804 |
| 5 | Basic earnings/(loss) per share (sen) | 6.80 | 8.20 | 37.30 | 30.80 |
| 6 | Dividend per share (sen) | 2.50 | 8.50 | 7.50 | |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 1.8000 | 3.2100 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 10 Apr 2003 |
| Category | Financial Results |
| Reference No | CR-030410-44189 |